How body fat talks to nearby colon tumors

Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link

NIH-funded research Utah State Higher Education System--University of Utah · NIH-11175459

This project looks at how excess body fat interacts with colon tumors in people across a range of weights to find targets that could help prevent obesity-related colon cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah NIH-funded
Lab location1 site (Salt Lake City, United States)
Project IDNIH-11175459 on NIH RePORTER

What this research studies

Researchers will collect blood, tumor tissue, and fat tissue next to the tumor from people with colon cancer, including those who are normal weight and those with obesity. They will search these paired samples for molecular signals that show how fat may fuel tumor growth. Promising targets found in patients will be tested in lab-grown organoids and in lean and diet-induced obese mouse models to see if blocking those signals slows or stops tumors. The goal is to combine human samples and experimental models to find practical ways to interrupt the link between obesity and colon cancer.

Who could benefit from this research

Good fit: Ideal candidates are adults with newly diagnosed colon cancer who can provide blood and allow collection of tumor and nearby adipose tissue, typically during surgical treatment.

Not a fit: People without colon cancer, those unwilling or unable to provide tissue samples, or patients not undergoing surgery to remove the tumor are unlikely to receive direct benefit from this work.

Why it matters

Potential benefit: If successful, this work could identify new ways to block harmful signals from fat and reduce the risk or progression of colon cancer in people with obesity.

How similar studies have performed: Prior research has linked obesity-related inflammation to higher colon cancer risk, but combining paired human tissue sampling with organoid and mouse experiments to pinpoint and block specific fat-to-tumor signals is a newer, more integrated approach.

Where this research is happening

Salt Lake City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.